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1. Introduction 
Atrial Fibrillation (AF) is characterised by rapid and disorganised depolarisation of the atria 
resulting in uncoordinated atrial contraction. It is the most common cardiac arrhythmia 
encountered in clinical practice increasing in prevalence with age and the presence of heart 
disease1 It is estimated that it affects 2.5 million people in the United States and 4.5 million in 
the European Union.2,3 The actual incidence of the arrhythmia may be much higher owing to 
undetected or asymptomatic patients within the population.  Since it is an age-associated 
arrhythmia its incidence has steadily risen over the past decade and will continue to 
increase due to a growing population of the elderly in the western world. Contributing risk 
factors include hypertension, diabetes, coronary artery disease, valvular disease, electrolyte 
imbalance.4 Patients with atrial fibrillation have a higher risk for stroke, heart failure and 
death.5Given the significant morbidity and mortality associated with AF and its associated 
economic burden, it is not surprising that there has been great interest in developing 
effective treatments for it. 
Atrial fibrillation is a supraventricular arrhythmia where uncoordinated rapid atrial 
contractions produce an irregular ventricular response. The atria may discharge between 
300-600 beats per minute but not all these impulses are conducted by the AV node. 
Ventricular response can be between 100-160 beats per minute in untreated patients with 
normal AV conduction.  This chaotic rhythm disrupts normal movement of blood through 
the heart reducing cardiac output and increasing the risk for thromboembolism such as 
stroke as a consequence of stasis of blood in the atria.6 
The serious morbidity and mortality associated with AF are attributed to three detrimental 
consequences: 
 Palpitations causing significant patient discomfort and anxiety  
 Loss of the coordinated atrioventricular contraction and “atrial kick” compromising 
cardiac haemodynamics and can lead to varying levels of ventricular dysfunction 
 Stasis and pooling of stagnant blood that can lead to intra-atrial thrombus formation 
and resulting in increased risk of thromboembolism 
Medical therapy remains the most common and first line treatment for patients with AF but 
frequently ineffective at restoring sinus rhythm leaving the patient susceptible to 
cardiovascular morbidity and mortality. Therefore, the goal of pharmacological therapy is 
often shifted from rhythm control (maintenance of sinus rhythm) to rate control (slowing 
the ventricular response to AF).7 
The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) trial 
demonstrated no survival benefit of rhythm control strategy over a rate control strategy. 
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Although rate control slows the ventricular response to AF, preventing tachycardia induced 
cardiomyopathy, it does not reduce the rates of thromboembolism or congestive heart 
failure. The atria are still in fibrillation and there is loss of the atrial “kick” resulting in 
worsening of congestive heart failure and requires indefinite anticoagulation with warfarin 
to counter the risk for developing thromboembolism. Although warfarin reduces the annual 
risk of ischaemic stroke and systemic thromboembolism to approximately 2%, its use is 
associated with significant morbidity with a 2% annual risk of drug associated 
haemorrhage.8,9,10 Anticoagulation may reduce lifetime relative risk of stroke by 60% but 
does not eliminate it11 
Although the results of the AFFIRM trial demonstrated no long-term benefit of rhythm 
versus rate control, some patients may still have advantages of being in sinus rhythm. These 
include freedom from palpitations, increased exercise tolerance and prevention of atrial 
remodelling. 12,13 
Ineffective results with rate and rhythm control strategies have helped to encourage the 
development of new interventional catheter and surgical treatments. Although catheter 
ablation is an established therapeutic option, the highest success rates are typically seen in 
patients with paroxysmal AF and minimal structural heart disease.14 
Therefore it is limited to a small number of patients treated by highly skilled 
electrophysiologists. On the other hand, almost all cardiac surgeons are capable of 
performing surgical ablation of AF. 
2. Classification of atrial fibrillation 
The terms used to classify and describe AF categorise it as paroxysmal, persistent, 
longstanding or permanent (figure 1). Paroxysmal AF is defined as at least two episodes of 
AF that terminate spontaneously within 7 days. If this is sustained beyond 7 days it is 
described as persistent. Another category of persistent AF includes longstanding AF, 
defined by duration of greater than one year. This usually leads to permanent atrial 
fibrillation in whom cardioversion has either failed or abandoned.15  
 
 
 
 
 
Fig. 1. Classification of Atrial Fibrillation 
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3. Electrophysiology of AF 
In recent years there has been considerable progress in understanding the pathophysiology 
of AF. It was initially thought that AF was caused by random, multiple wavelets generated 
throughout the atria that propagated new wavelets to cause re-entry mechanism. In the 
1980s, several procedures were developed aimed at curing atrial fibrillation. However, most 
of these were abandoned due to their inability to address all three detrimental sequelae of 
atrial fibrillation. It was discovered that electrical impulses were incapable of crossing areas 
of the heart that had been incised and sutured.16,17 
This fostered the development of the Maze procedure, designed and first reported by Cox 
and colleagues in which multiple incisions were made and sutured in a manner that blocked 
the aberrant impulses within the atrium (figure 2). These incisions directed the SA node 
impulse to initiate and propagate throughout the atria to the AV node along a specified 
route created by the Maze incisional lesions18. However, recently studies have demonstrated 
that the initiation of paroxysmal but not necessarily persistent or permanent AF are 
generated by electrical waves from focal sources, particularly near the pulmonary veins. 
Haissaguerre et al.19 mapped the triggers of paroxysmal AF to originate around the orifices 
of the pulmonary veins in 94% of patients with atrial diameters of less than 5cm. These 
findings have directed the development of more precisely targeted procedures that can be 
performed less invasively with less destruction of normal tissue. 
 
 
Fig. 2. The pathway taken in the atria by the aberrant impulses in atrialfibrillation (arrows). 
The thick lines are the ablation lesions used in the Maze procedure. Key-  SAN: sino-atrial 
node, AVN: atrio-ventricular node,  RAA: right atrial appendage, LAA: left atrial 
appendage, SVC: superior vena cava, IVC: inferior vena cava, PVs: pulmonary veins. 
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A key concept in understanding the development of persistent atrial fibrillation is that the 
atria undergo electrical remodelling. Atrial electrical remodelling results in shortening of the 
atrial refractory period, myocyte calcium overload, decreased conduction velocity, 
dispersion of conduction and increased sensitivity to catecholamines4,20,21,22. This 
phenomenon may be reversed after maintenance of sinus rhythm23. The more a patient 
experiences AF, the more susceptible they are to continue fibrillating as a result of 
remodelling. Therefore AF can become a self-sustaining arrhythmia once atrial remodelling 
has occurred. Micro-reentrant triggers are then no longer necessary and limited to 
pulmonary venous impulse-triggering sites.24 Therefore, treatment for persistent or 
longstanding AF directed at the pulmonary veins only is likely to be unsuccessful. 
4. Non pharmacological therapy 
When pharmacological intervention is unsuccessful or contraindicated in patients, non-
pharmacological therapy may be attempted. These include synchronised electrical 
cardioversion, catheter based ablation techniques or surgical intervention.25,26,27. Direct-
current cardioversion differs from defibrillation whereby the shock is synchronised to the R 
wave in the patient’s ECG. The patient must be adequately anticoagulated during electrical 
cardioversion in order to prevent disruption of a pre-existing intra cardiac thrombus which 
will cause it to embolize to the brain or systemic circulation. The risks of electrical 
cardioversion include hypotension, bradycardia, pulmonary oedema, systemic 
embolization, skin burns and ventricular arrhythmias.28 Risks of emboli range from 0.5% to 
3% and is further multiplied in patients who experience recurrence and treated with serial 
cardioversions.29,30 
Catheter based ablation techniques were initially developed following Cox’s pioneering 
work with the Maze procedure. These techniques were further influenced by research that 
demonstrated ectopic foci surrounding pulmonary veins. Isolation of the pulmonary veins 
remains the cornerstone of most AF catheter ablation procedures.  Following heparinization, 
a percutaneous catheter placed into the femoral vein is advanced to the right atrium. The left 
atrium is accessed via an interatrial septal puncture. Lesions are created around the 
pulmonary veins using cryoenergy or radio-frequency energy. These techniques have 
shown a higher success in treating patients with paroxysmal AF compared to those with 
enlarged left atrium and persistent or permanent AF.31,32 Complications of catheter ablation 
include cardiac tamponade, atrioesophageal fistula and stroke33 
5. Surgical treatment 
Surgery is indicated in patients undergoing elective cardiac surgery that have symptomatic 
AF or those with asymptomatic AF with low operative risk.34 It is advised that patients with 
persistent or permanent AF scheduled for elective cardiac surgery should be considered for 
concomitant ablation procedure that may increase both short-term and long-term freedom 
from AF, in addition to lowering the risk of thromboembolism and improving long term 
survival and cardiac function35. Surgery for lone AF may be considered in certain 
circumstances where patients have failed to respond to catheter ablation or in whom 
catheter ablation is contraindicated such as a mural thrombus. Patients that develop 
tachycardia-induced cardiomyopathy will also benefit from surgery. It results in atrial or 
ventricular dysfunction as a result of increased heart rates in an otherwise structurally 
normal heart.36 If left untreated it can lead to heart failure and is reversible if sinus rhythm is 
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restored.37 In addition patients in whom anticoagulation is contraindicated may also be 
suitable candidates that may benefit from surgical intervention following failure of catheter 
based ablation. Patients that continue to experience thromboembolic events despite 
adequate anticoagulation may also benefit from surgery.38  
Several procedures were developed in the 1980s aimed at finding a cure to atrial fibrillation. 
Hoewever, most of these procedures were subsequently abandoned due to their inability to 
address all three of the detrimental sequelae of AF. Early attempts at surgical treatment of 
AF attempted to isolate and confine AF to a specific region of the atria and thereby stopping 
it from propagating its effects upon the ventricles. The left atrial isolation procedure 
developed by Williams and colleagues was successful in confining AF to the left atrium and 
thus restoring sinus rhythm to the rest of the heart.39 It also removed two of the 3 
detrimental consequences attributed to AF namely, irregular heart rate and compromised 
haemodynamics. The latter was achieved because restoring sinus rhythm on the right side 
permitted a normal right-sided cardiac output that was delivered to the left side of the heart. 
The left ventricle responded to the normal cardiac output on the right side by delivering a 
normal cardiac output. Since the left atrium continued to fibrillate this procedure did not 
reduce the risk of thromboembolism. The ‘Corridor’ procedure was introduced in 1985 that 
isolated a strip of atrium that contained both the SA node and AV node from the rest of the 
atria to create a continuous pathway (corridor) directing the impulses from the SA node to 
the AV node to maintain sinus rhythm.  Since parts of the right and left atrial were free to 
fibrillate it did not eliminate the risk of thromboembolism and nor did it restore 
atrioventricular synchrony.  
Cox and colleagues described a series of experiments that attempted to cure AF in dogs. A 
single incision across both atria successfully prevented AF and atrial flutter. Further 
investigations by Cox and colleagues led to the Cox-Maze procedure in 1987.16,17,40 The 
procedure itself was based upon a cut and sew technique whereby multiple incisions were 
made in the atria. This created lines of scar that interrupted the conduction routes of the 
most common re-entrant circuits, thus preventing AF or atrial flutter by directing the sinus 
node impulses along a specified route. It was based around the concept of a maze and as a 
result was called the Cox-Maze procedure. In contrast to the previous surgical techniques, 
this was the first that addressed all three sequelae of AF and restored sinus rhythm, AV 
synchrony and thus significantly reducing the risk of thromboembolism and stroke.41 The 
original procedure, known as Cox-Maze I was complicated with a high incidence of heart 
block requiring pacemaker implantation. It also resulted in the late incidence of two 
problems. Firstly it led to the frequent inability of patients to generate an appropriate sinus 
tachycardia and secondly left atrial dysfunction. This was modified to the Cox Maze II 
procedure which despite decreased incidence of conduction system injury was technically 
difficult. It was therefore modified to the Cox-Maze III procedure that was associated with a 
higher incidence of sinus rhythm and improved long-term sinus node function and atrial 
transport function.40 In this procedure several dead-end “alleyways “create a maze-like 
pathway and permit the depolarization of all the atrial tissue. The Cox Maze III procedure 
can be performed both through median sternotomy as well as a partial lower sternotomy. 
The patient is fully heparinized and the surgeon cannulates the patient for cardiopulmonary 
bypass after dividing the sternum. Bicaval cannulation is achieved. The right atrial 
appendage is excised and a series of incisions are made to the right atrium including a 
cryolesion. The aorta is occluded preparing for the left atrial portions of the operation. Cold 
blood potassium cardioplegia is administered via retrograde perfusion of the coronary 
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sinus. The left atrium is exposed by an incision posterior to the interatrial groove close to the 
orifices of the right pulmonary veins. A number of incisions are made across the left atrium 
and the left atrial appendage is excised at its base. The incisions to the left atrium interatrial 
septum and right atrium are closed. Despite its complexity, the Cox-Maze III procedure 
became the gold standard for surgical treatment of AF. It has been performed in hundreds 
of patients and proven to be highly successful in ablating any form of AF irrespective of 
whether patients had concomitant heart disease or not.42,43 Although it adds to 
cardiopulmonary bypass and cardiac arrest time it does not increase the operative 
mortality.44,45 
Sinus rhythm was reported in 97% at late follow-up and it was equally effective in patients 
with lone AF as those undergoing concomitant cardiac surgery.44,46 Similar results were 
reproduced by other institutions across the world.47,48Early postoperative AF is common 
following a maze procedure and usually abates by 3 months.44,46 In addition to restoring 
sinus rhythm the maze procedure is associated with additional clinical benefits for the 
patients. In those with mitral valve disease restoration of sinus rhythm improves survival. 
Risks for stroke, systemic thromboembolism and anticoagulant-related haemorrhage are 
also reduced.41,49The freedom from late stroke is likely to be from restoration of sinus 
rhythm as well as excision of the left atrial appendage, an integral part of the maze 
procedure.50 
Despite the excellent results of the cut and sew maze procedure, few surgeons adopted the 
procedure due to its technical difficulty and is almost obsolete today. Advances in the 
understanding the pathophysiology of AF and newer ablation technologies fostered the 
development of novel strategies aimed at simplifying the procedure to make it more 
accessible to the average surgeon without compromising the results.  
Use of ablative energy sources has enabled to replace most of Cox III incisions with a variety 
of energy sources including radiofrequency, cryoablation and high frequency ultrasound.  
The development of these technologies has rendered a technically difficult and time-
consuming operation easy for all cardiac surgeons to perform. Ablation technologies have 
also helped foster the development of less invasive procedures through a small incision or 
port. In order to replace the incision in AF surgery, ablation technology must meet several 
requirements. It must reliably produce transmural lesion either from the epicardial or 
endocardial surface to ensure bidirectional conduction block. It should also be safe  and 
render AF surgery simpler and less time consuming to perform. It would also be adaptable 
to minimally invasive approach. Melby and colleagues51 described procedure that replaced 
with cut-and-sew lesions with bipolar radiofrequency lines as the Cox-Maze IV. In this 
technique, the atrial septal lesion was not performed and an independent isolation of the 
pulmonary veins was made with a connecting lesion. Although bipolar radiofrequency may 
reliably produce transmural lines and applied minimally invasively for pulmonary veins, it 
does not permit secure performance of connecting lines in the left atrial isthmus or inside 
the right atrium.53,54  
Early follow-up suggests that the Cox-Maze IV procedure is similar in efficacy  with 91% of 
patients having freedom from AF at 6 months.55 There was no operative mortality and the 
group had significantly shorter cross clamp time compared to the Cox Maze III group. Cox 
also suggested another simplified procedure to cure most patients of AF.56 This involved three 
essential lesions that include 1.an incision encircling the pulmonary veins, 2.left atrial isthmus 
and companion coronary sinus lesions and 3.right atrial isthmus lesion. This modified Cox-
Maze procedure has been shown to be nearly as effective as the Cox-Maze III.57  
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6. Lesion sets for the surgical treatment of atrial fibrillation 
Three general categories of lesion sets exist for the surgical treatment of AF in adults: 
 Pulmonary vein isolation 
 Left atrial lesion set 
 Biatrial lesion set 
Pulmonary vein isolation is only an ideal choice for those who have new onset paroxysmal 
AF Lesions can be created using a variety of different approaches that include beating heart 
epicardial techniques or on pump endocardial approaches that use energy devices or the cut 
and sew technique. Pulmonary vein isolation can be achieved through either a single lesion 
encircling all pulmonary veins or two lesions encompassing the left and right pulmonary 
veins. Left atrial lesion sets are advised in patients with recent-onset or paroxysmal AF 
undergoing elective surgery with no justification to open the right atrium. This includes 
pulmonary vein isolation with the addition of linear lesions extending to the mitral annulus 
and left atrial appendage that is usually excised or excluded. This is because more than 90% 
of left atrial thrombi originate from the left atrial appendage in patients with non-rheumatic 
AF.58 Biatrial lesion sets are the most effective treatment option for AF59. Patients with 
longstanding or symptomatic AF, young patients or those undergoing right heart surgery 
would benefit from this procedure60  
The Cox maze IV procedure is performed with the patient on CPB with bicaval cannulation. 
Using blunt dissection, the right and left PVs are dissected. If the patient is in AF, they are 
cardioverted. Pacing thresholds are obtained from all PVs. The bipolar ablation is performed 
around the cuff of atrial tissue surrounding the right and left pulmonary veins.  Pacing is 
used to confirm block from both the superior and inferior PVs. Following PVI, the right 
atrial lesions are performed with the heart beating. An incision is created in the right atrial 
appendage as shown in figure 3. The bipolar device is used to make a right atrial free wall 
lesion. Following this a vertical right atriotomy is made around 2cm from the free wall 
ablation that extends from the crista terminalis toward the intra-atrial septum. The incision 
is then extended superiorly toward the AV groove. Two cryolesions are placed at the 
tricuspid annulus using cryoprobe. The bipolar clamp is used to create linear ablation lines 
from the SVC down to the IVC. The SVC ablation is made as laterally as possible to avoid 
damage to the SA node. The left sided atrial lesions are performed through a standard left 
atriotomy. This extends superiorly onto the dome of the left atrium and inferiorly around 
the orifice of the right inferior pulmonary vein. A lesion is made with the bipolar RF device 
to create a connecting lesion between the left atrial incision inferiorly to the ablation line 
encircling left inferior pulmonary vein. In atria greater than 5cm in diameter,  a second 
connecting ablation is placed from the superior aspect of the incision into the left superior 
pulmonary vein. Finally, a bipolar radiofrequency ablation line is performed from the 
inferior aspect of the left atrial incision across the mitral valve annulus at a point between 
the circumflex and right coronary artery circulation. A cryolesion is placed at the mitral 
valve annulus. The left atrial appendage is amputated and a bipolar RF ablation is 
performed between the amputated left atrial appendage and superior PV. The left atrial 
appendage is oversewn. The aorta is unclamped and the right atrial incision is closed. 
Patients with lone atrial fibrillation can choose between a catheter based approach or a 
minimally invasive surgical technique. Minimally invasive surgery to treat lone atrial 
fibrillation also can benefit patients who have a contraindication to warfarin, antiarrhythmic 
medications, or a history of cerebrovascular events. The procedure involves groin  
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Fig. 3. Cox-Maze IV procedure 
cannulation to connect the patient to CPB. The right sided lesions can be completed on a 
beating heart with or without cardiopulmonary support. After cross clamping the aorta, left 
sided lesions are created in a similar pattern to the Cox-Maze II procedure, creating a box 
lesion around all the pulmonary veins with a connecting lesion to the left atrial appendage 
and to the mitral valve isthmus. The left atrial orifice is closed from the endocardial side. 
When performed correctly, the results of the minimally invasive approach are excellent.61  
Minimally invasive surgical techniques have been an area of interest as an alternative to 
catheter based pulmonary vein isolation. Bilateral thoracotomies or mini sternotomy can be 
used to isolate the pulmonary veins62,63. Its major advantage is that it can be performed in 
the absence of cardiopulmonary bypass and in many cases left atrial appendage 
disarticulation can also be offered.  However, since AF does not always originate in the 
pulmonary veins this is not suitable in all patients, particularly those with non-paroxysmal 
AF.  
Surgery for AF reduces medical costs successfully. When performed in conjunction with 
elective cardiac surgery it is cheaper and more effective than medical or catheter based 
therapy at a later time and cost effective in patients with a good prognosis64,65 In summary, 
surgery for AF has evolved during the previous 2 decades to include several different 
approaches, lesion sets and energy sources. All patients undergoing concomitant cardiac 
surgery with AF should undergo surgical treatment for their AF. Ablation technology has 
simplified the procedure to make it easy for all surgeons to adopt and pave way towards 
minimal access procedures. 
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